Almac’s Clinical Technologies division has passed one of the UK’s first joint routine GCP/GMP Medicines and Healthcare Products Regulatory Agency (MHRA) inspections at its Craigavon, UK site. Senior MHRA inspectors from both its GCP and GMP areas assessing compliance with UK and European legislation. The MHRA inspection was conducted on the GMP side to determine whether Almac’s IXRS integrated phone and web response system was able to adequately ensure that expired products ...